Pharmacists in North Richland Hills, Texas


60 Pharmacists found in North Richland Hills
female pharmacist

Ross Phan, PHARMD, BCPS


Pharmacist
7656 Regal Ln, North Richland Hills, TX 76180
805-391-7974    

female pharmacist

Dr. Simone L Mallet, PHARM D


Pharmacist
7804 Shady Oaks Dr, North Richland Hills, TX 76182
817-675-7982    

female pharmacist

Dr. Sophia Xi Wang, R.PH.


Pharmacist
5621 Havana Dr, North Richland Hills, TX 76180
682-433-6192    



female pharmacist

Dr. Stephanie Oh Gonzales, PHARMD


Pharmacist
7213 W Nirvana Cir, North Richland Hills, TX 76182
512-777-9939    

female pharmacist

Tara Lianne Fink, PHARM.D.


Pharmacist
6401 Ne Loop 820, North Richland Hills, TX 76180
817-498-4411    

male pharmacist

Thanh Do


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
9150 N Tarrant Pkwy, North Richland Hills, TX 76182
817-918-3387    

male pharmacist

Thomas Obrzut I


Pharmacist
8955 N Tarrant Pkwy, North Richland Hills, TX 76182
817-428-2585    

female pharmacist

Tiffanie Nguyen


Pharmacist
6320 Rufe Snow Dr, North Richland Hills, TX 76148
817-656-9861     817-581-6796

female pharmacist

Van Nguyen, PHARM. D.


Pharmacist
9101 N Tarrant Pkwy, North Richland Hills, TX 76182
817-605-8190    

female pharmacist

Vanessa Doan


Pharmacist
6984 Rufe Snow Dr, North Richland Hills, TX 76148
817-427-9353    

male pharmacist

Vince Van Le


Pharmacist
6401 Precinct Line Rd, North Richland Hills, TX 76182
817-485-8302    

female pharmacist

Vivian Nguyen


Pharmacist
6401 Ne Loop 820, North Richland Hills, TX 76180
817-498-4411    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.